Your search

Filter the results

By type of result

By number of elements

9 results

Team 2 - Helicobacter infection: Inflammation and Cancer (31 October 2018)

. Our main research axes: Gastric MALT lymphoma and in particular on inflammatory and molecular responses in animal model of gastric MALT lymphoma development (Philippe Lehours) Cancer stem cells ... Team 2 research is dedicated to the study of the pathogenicity of Helicobacter, in particular in the context of digestive cancers associated to Helicobacter infection: Helicobacter pylori infection ... Team 2 - Helicobacter infection: Inflammation and Cancer

The word from the Director (10 April 2017)

, microenvironment interaction, cancer cell stemness and signaling pathways. Clinicians, pathologists, bacteriologists and geneticists of the University Hospital of Bordeaux are members of the teams that permits

The word from the Director (14 October 2017)

, microenvironment interaction, cancer cell stemness and signaling pathways. Clinicians, pathologists, bacteriologists and geneticists of the University Hospital of Bordeaux are members of the teams that permits

Group V. Moreau (25 June 2018)

is a characteristic of malignant cancer cells and is one component of metastasis, the major clinical problem in cancer. Consequently, alterations in cytoskeletal signalling pathways are increasingly being recognized ... Our research focuses on the molecular bases of hepatic tumor cell invasion.

Team 3 - Oncogenesis of cutaneous lymphomas (12 February 2018)

Team leader Jean-Philippe MERLIO, PU-PH jp.merlio@u-bordeaux.fr +33 (0)5 57 57 10 27   Research description Cutaneous lymphomas are a fascinating cancer subtype with analysis at different ... Cutaneous lymphoma as a general model to study lymphoid cells oncogenesis

Group M. Bouchecareilh (07 February 2018)

, Bodineau C, Vacher P, Priault M, Soubeyran P, Durán RV. mTOR inhibition protects from glutaminolysis-mediated apoptosis in cancer cells during nutrient limitation. Nat Commun. 2017 Jan 23;8:14124. doi: 10 ... Our research focuses on the identification of biomarkers and new therapeutic targets involved in liver physiopathology (Rare disease: Alpha 1-Antitrypsin Deficiency and Cancer: Hepatocellular

Publication from Team 1 in JCB (06 April 2017)

the protrusion-localization sequence in p190A and show that cancer-associated mutations in this region affect p190A localization and function as well as tumor cell migration. related publication: Journal of Cell

Group F. Saltel (05 June 2018)

Research Metastases development at a distance from a primary site of cancer represents the principal cause of cancer-related mortality. Presently, there is no efficient way to block tumor cell

Translational Research (25 June 2018)

transformation. Cancer Cell. 2014 Apr 14;25(4):428-41.